Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v8-FR
Language French French
Date Updated 2020-04-30 2020-03-31
Drug Identification Number 02296454 02296454
Brand name ENGERIX-B ENGERIX-B
Common or Proper name Hepatitis B vaccine (recombinant) Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS B SURFACE ANTIGEN HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG 10MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (Vial / Fiole) 1's (Vial / Fiole)
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-04-30 2020-04-20
Actual discontinuation date 2020-04-24
Remaining supply date 2021-04-30 2021-04-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments This pack size has been discontinued. This pack size has been discontinued.
Health Canada comments